This CV Business White Paper explores the rationale and best practices for improving lipid management post-ACS as framed by the ACC’s TRANSFORM-ACS initiative. This document provides a solution-focused resource to support the clinical team in achieving early lipid measurement and initiation of guideline-directed lipid-lowering therapies during ACS hospitalization, ensuring follow-up lipid testing in the ambulatory setting to facilitate rapid achievement of LDL-C targets in the secondary prevention of atherosclerotic cardiovascular disease.
By continuing to use our site, you agree to our Cookie Policy, Privacy Policy and Terms of Use.